ACAlexis Chow

Alexis Chow

*This is an algorithmically generated author record based on publicly available information.

Alexis Chow has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Identifying the diagnostic utility of artificial intelligence for elbow effusion detection: A systematic review and meta-analysis

    by Alexis R. Chow, Jonathan Elias, Kunal Shah, Robert Ablove, Sean Mcmillan

    Introduction: Elbow fractures are often difficult to assess on radiographs, and joint effusions may be the only indication of a fracture. As radiologists may not always be available in the acute care setting, the use of artificial intelligence (AI) for effusion detection may be beneficial. This systematic review and meta-analysis analyzes the sensitivity and specificity of AI for elbow effusion detection and compares them to physician radiographic interpretations. We hypothesize there will be no significant differences between the diagnostic utility of AI and physicians. Methods: A systematic review and meta-analysis was performed on five databases (Cochrane, Embase, Scopus, PubMed, Web of Science). Included studies reported numbers of true positives, true negatives, false positives, false negatives, the number of radiographs, sensitivity, specificity, and positive and negative predictive values. A bivariate random-effects meta-analysis was performed in R Studio v.4.5.1 to calculate sensitivity, specificity, and area under the curve (AUC), as well as 95% confidence intervals for sensitivity and specificity. Results: Four retrospective studies were included in the analysis, encompassing 5790 radiographs. (2–5) AI software had a sensitivity of 92.7% (95% CI: 75.3–98.2%), specificity of 97.8% (95% CI: 84.3–99.7%), AUC of 97.8%, and normalized AUC of 95.8%. There was minimal heterogeneity between the AI studies (I 2 = 39.3%). Physicians, including residents and attendings, had a sensitivity of 94.8% (95% CI: 85.5–98.3%), specificity of 96.8% (95% CI: 84.2–99.4%), AUC of 97.9%, and normalized AUC of 94.6%. There was no significant heterogeneity between the physician studies (I 2 = 0%). There was no significant difference between AI and physicians in sensitivity ( p = 0.79) or specificity ( p = 0.82). Discussion: No significant differences were observed between the radiologists and the AI software, with both groups yielding high specificity and sensitivity, indicating comparable performance.

  • Open Access

    Examining the Role of Corticosteroids in the Management of Acute Interstitial Pneumonia: A Systematic Review

    by Carlos Valladares, Aalia Narvel, Bianna Koutsenko, Alexa Simonetti, Fatima Mossolem, Alexis Chow, Samrat Gollapudi, Usmaan Al-Shehab, Nicholas Averell, Katherine Chiapaikeo-Poco, et al.

    Background: Acute interstitial pneumonia (AIP), also known as Hamman-Rich syndrome, is a rapidly progressive interstitial lung disease. In addition to being challenging to diagnose, AIP is also difficult to treat. The mortality rate of AIP is greater than 70% due to the disease’s rapid progression. Furthermore, survivors are likely to develop chronic interstitial lung disease as a sequela. Treatment primarily focuses on supportive care, which consists of oxygenation through mechanical ventilation, administration of broad-spectrum antibiotics, and the use of corticosteroids. Although the use of steroids as empiric treatment is controversial and results on its mortality benefit are variable, some studies have shown high-dose pulse steroid therapy to be associated with better health outcomes. This review aimed to evaluate cases of AIP to better understand the role of corticosteroids in the management plan of these cases. Methods: A systematic review was conducted using the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 guidelines. Outcomes of interest included patient age, sex, autoimmune condition, corticosteroid use, survival or expiration of patients, and time from hospitalization to expiration. Results: Initial querying of the five databases yielded 376 articles. Following a thorough review, only 30 articles remained, comprising 42 patient cases. Of these cases, 62% of the patients survived, 36% expired, and 2% were unknown. The average stay from hospitalization to death was 20.2 days, and corticosteroid pulse doses were used as a first- or second-line treatment in 31% of patients. Conclusion: The limitations of the evidence used in this study highlight the need for a greater output of higher-level evidence in the form of controlled trials and retrospective studies to help further elucidate the proper role and dosage of corticosteroids in the management plan of AIP with the ultimate goal of enhancing clinical decision-making and patient care. The findings of this systematic review, primarily based on observational data from case reports, highlight the critical need for treatment guidelines for this condition. The compilations of these cases also illustrated the diverse strategies employed by clinicians globally to save patients afflicted by this condition. While specific recommendations cannot be made based solely on these results, we anticipate that this comprehensive overview of varied clinical approaches from around the world will serve as a valuable resource for healthcare providers navigating the complexities of managing this condition.


  • THE USE OF WEARABLES AND SMART PHONE APPS FOR A NON-INFERIOR RECOVERY AFTER LOWER LIMB TOTAL JOINT ARTHROPLASTY: A SYSTEMATIC REVIEW AND META-ANALYSIS

    by Alexis Chow, Mitchell Kaplan, Kunal Damaraju, Taylor Carmichael, Richard Jermyn

    Background: With an increasing trend toward home-based rehabilitation, it is important to distinguish non-inferior and improved virtual rehabilitation methods. A Systematic review and meta-analysis were conducted to examine the effect of combined digital rehabilitation, including smartphone applications and wearable devices, on quality of life following total joint arthroplasty (TJA), total knee arthroplasty (TKA), and total hip arthroplasty (THA) in comparison to standard of care physical therapy (PT). Methods: A systematic review and single-proportion meta-analysis was conducted employing the PRISMA 2020 guidelines in January 2024. A comprehensive review of the literature was conducted, yielding four randomized controlled trials, encompassing a sample size of 496 patients who underwent combined digital rehabilitation. Results: Differences in quality of life using EQ-5D-5L were non-significant between groups ([ ] = 0.35, [ ] = 0.56). In the combined digital group, knee ROM was non-significantly increased ([ ] = 0.23, [ ] = 0.63) and KOOS JR was non-significantly decreased ([ ] = 1.04, [ ] = 0.31). Conclusions: Adhering to specified inclusion and exclusion criteria, there was limited data available regarding the impact of applications and wearable devices on THA patients. Consequently, our analysis included a single available study that employed the EQ-5D-5L measurement for THA patients. More studies involving wearable devices and digital applications should be considered in order to further test the efficacy of these treatments for TJA compared to standard treatment modalities. Despite this limitation, the findings of this review indicate that at-home treatment using wearable devices and digital applications yields outcomes comparable to those achieved through conventional treatment models for patient rehabilitation. Furthermore, at-home wearable and digital treatments may present a cost-effective and convenient alternative to in-person treatment.

  • 43Dynamic atrioventricular delay achieves superior electrical synchrony when pacing both ventricles rather than left ventricle alone

    by B Thibault, A Chow, J Mangual, N Badie, P Waddingham, L Mcspadden, T Betts, L Calo, F Leyva

    Funding Acknowledgements: Abbott Introduction: Automatic adjustment of atrioventricular delay (AVD) with SyncAV has been shown to improve electrical synchronization when pacing one or two sites in the left ventricle together with the right ventricle. However, it is unknown if the same benefit can be gained by using SyncAV while pacing only the left ventricle without right ventricular pacing. Purpose: Evaluate the acute improvement in electrical synchrony provided by SyncAV with and without MultiPoint Pacing (MPP) during biventricular (BiV) and LV only pacing. Methods: Patients with LBBB and QRS duration (QRSd) ≥ 150 ms scheduled for CRT-P/D device implantation with quadripolar LV lead were enrolled in this prospective study. QRSd was measured post-implant from 12-lead surface electrograms by blinded experts during the following pacing configurations: intrinsic conduction, conventional BiV (BiV = RV + LV1), MPP (MPP = RV + LV1 + LV2), LV-only single-site (LVSS = LV1 only), and LV-only MPP (LVMPP = LV1 + LV2). For each pacing mode, SyncAV was enabled (e.g. BiV + SyncAV) with the patient-tailored SyncAV offset that minimized QRSd. As an additional reference, QRSd during BiV was also measured using the nominal static AVD (paced/sensed AVD = 140/110 ms). BiV and LVSS pacing used the latest activating LV cathode, whereas MPP and LVMPP used the two LV cathodes with the widest possible separation (>30mm). All configurations used the minimum programmable RV-LV and LV1-LV2 delays. Results: Thirty-five patients (78% male, 33% ischemic, 26% ejection fraction, 165 ms intrinsic QRSd) completed device implant and QRSd assessment. Relative to intrinsic conduction, BiV with nominal AVD reduced the QRSd by 17.5% (p < 0.001 vs intrinsic). Enabling SyncAV with a patient-optimized offset significantly improved QRSd reduction. BiV + SyncAV reduced QRSd by 25.2% (p < 0.001 vs. BiV). The greatest QRSd reduction of 28.9% was achieved by MPP + SyncAV (p < 0.01 vs. BiV + SyncAV). Single- and multi-site LV-only pacing reduced QRSd significantly less than corresponding biventricular modes. LVSS + SyncAV reduced QRSd by 22.5% (p < 0.05 vs. BiV + SyncAV), and LVMPP + SyncAV reduced QRSd by 24.3% (p < 0.05 vs. MPP + SyncAV). As a percent of PR interval, optimal SyncAV offsets were similar for BiV + SyncAV (median: 13%, mean: 17%) vs. MPP + SyncAV (median: 13%, mean 16%, p = 0.35 vs. BiV + SyncAV), and similar for LVSS + SyncAV (median: 20%, mean: 28%) and LVMPP + SyncAV (median: 23%, mean: 26%, p = 0.35 vs. LVSS + SyncAV), but were significantly higher for LV-only settings vs. corresponding BiV/MPP settings (p < 0.01 for both pairs). Conclusion: Greater improvement in electrical synchrony using SyncAV was observed when right ventricular pacing was included with left ventricular pacing. Additional benefit was gained by the addition of a second left ventricular pacing site with MPP in combination with SyncAV in both biventricular and LV only pacing modes. Abstract Figure.

  • 862Syncav with multipoint pacing improves acute left ventricular hemodynamics

    by A Chow, P Waddingham, T Betts, J Mangual, N Badie, L Mcspadden, C Pappone, L Calo, F Leyva, B Thibault

    Funding Acknowledgements: Abbott Introduction: SyncAV has been shown to improve electrical synchronization by automatically adjusting atrioventricular delay (AVD) according to the intrinsic atrioventricular conduction time. Additional incremental electrical synchronization may be gained by the addition of second left ventricular (LV) pulse with MultiPoint Pacing (MPP). While the electrical synchronization benefits of SyncAV have been previously explored, there has been no assessment of the acute hemodynamic impact of SyncAV with or without MPP. Objective: Evaluate the acute LV hemodynamic impact of SyncAV with and without MPP. Methods: Heart failure patients with LBBB and QRS duration (QRSd) > 140 ms undergoing CRT-P/D implant with a quadripolar LV lead were enrolled in this prospective study. A guidewire or catheter with pressure transducer was placed in the LV chamber and the maximum pressure change (dP/dtmax) was recorded during the following pacing modes: intrinsic conduction, conventional biventricular pacing with SyncAV (BiV + SyncAV), and MPP with SyncAV (MPP + SyncAV). Twelve-lead surface ECG was used to determine the patient-tailored SyncAV offset that minimized QRSd. Results: Twenty-seven patients (67% male, 44% ischemic, 30 ± 7% ejection fraction) completed the acute recordings. Relative to the intrinsic QRSd of 163 ms, BiV + SyncAV reduced QRSd by 21.5% to 124 ms (p < 0.001 vs. intrinsic) and MPP + SyncAV reduced QRSd by 26.6% to 120 ms (p < 0.05 vs. BiV + SyncAV). Beyond electrical synchronization, SyncAV significantly improved acute hemodynamics. Relative to the intrinsic dP/dtmax of 842 mmHg/s, BiV + SyncAV elevated dP/dtmax by 6.3% to 900 mmHg/s (p < 0.001 vs. intrinsic) and MPP + SyncAV elevated dP/dtmax by 8.8% to 926 mmHg/s (p < 0.005 vs. BiV + SyncAV). Despite both QRSd and dP/dtmax improvement with SyncAV and MPP, correlation between electrical and hemodynamic measurements was poor (R2 = 0.0 for BiV + SyncAV, R2 = 0.1 for MPP + SyncAV). Conclusion: SyncAV may significantly improve acute LV hemodynamics in addition to electrical synchrony in LBBB patients. Further incremental improvement was achieved by combining SyncAV with MPP. Abstract Figure.